Fibromyalgia: A new treatment option for fibromyalgia

Robert M. Bennett

    Research output: Contribution to journalArticlepeer-review

    3 Scopus citations


    The FDA’s approval of milnacipran reflects advances in the development of drugs aimed at modulating pain circuitry in fibromyalgia.

    Original languageEnglish (US)
    Pages (from-to)188-190
    Number of pages3
    JournalNature Reviews Rheumatology
    Issue number4
    StatePublished - Apr 2009

    ASJC Scopus subject areas

    • Rheumatology


    Dive into the research topics of 'Fibromyalgia: A new treatment option for fibromyalgia'. Together they form a unique fingerprint.

    Cite this